Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/148230/1/ijc32029.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/148230/2/ijc32029_am.pd
Purpose: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Because both ovarian and breast cancer are hormone-related and are known to have some predisposition...
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
We previously identified associations with ovarian cancer outcome at five genetic loci. To identify ...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
We previously identified associations with ovarian cancer outcome at five genetic loci. To identify ...
To access publisher's full text version of this article click on the hyperlink belowLarge-scale geno...
Ovarian cancer (OC) accounts for more deaths than all other gynecological cancers combined. To ident...
This study evaluated single nucleotide polymorphisms (SNPs) associated with progression free (PFS) a...
The Ovarian Cancer Association Consortium selected 7 candidate single nucleotide polymorphisms (SNPs...
BACKGROUND: Many epithelial ovarian cancer (EOC) risk factors relate to hormone exposure and elevate...
Large-scale genome-wide association studies (GWAS) have identified approximately 35 loci associated ...
As a follow-up to genome-wide association analysis of common variants associated with ovarian carcin...
As a follow-up to genome-wide association analysis of common variants associated with ovarian carcin...
Purpose: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Because both ovarian and breast cancer are hormone-related and are known to have some predisposition...
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
We previously identified associations with ovarian cancer outcome at five genetic loci. To identify ...
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explai...
We previously identified associations with ovarian cancer outcome at five genetic loci. To identify ...
To access publisher's full text version of this article click on the hyperlink belowLarge-scale geno...
Ovarian cancer (OC) accounts for more deaths than all other gynecological cancers combined. To ident...
This study evaluated single nucleotide polymorphisms (SNPs) associated with progression free (PFS) a...
The Ovarian Cancer Association Consortium selected 7 candidate single nucleotide polymorphisms (SNPs...
BACKGROUND: Many epithelial ovarian cancer (EOC) risk factors relate to hormone exposure and elevate...
Large-scale genome-wide association studies (GWAS) have identified approximately 35 loci associated ...
As a follow-up to genome-wide association analysis of common variants associated with ovarian carcin...
As a follow-up to genome-wide association analysis of common variants associated with ovarian carcin...
Purpose: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hy...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Because both ovarian and breast cancer are hormone-related and are known to have some predisposition...